Statistics
Publications
2
Citations
55
H-Index
2
Active since
2019
Affiliations
Tulane University(Current)
Isabella Van Savage is an author at Tulane University specializing in gene dosage effects, copy number variants, and triple-negative breast cancer therapy.
Publications per year
2019–2022
2
2
Ceritinib is a novel triple negative breast cancer therapeutic agent
Shengli Dong, Hassan Yousefi, Isabella Van Savage et al. · Molecular Cancer · 2022 · 35 citations · Full text
Medicine, Oncology, Pharmacology +16
Xinli Tian, Adam D. Richard, Madison Wynne El-Saadi et al. · Molecular Psychiatry · 2019 · 20 citations
1–2 of 2